Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

4.43
-0.7700-14.81%
Volume:231.41K
Turnover:1.04M
Market Cap:6.69M
PE:-0.11
High:4.80
Open:4.80
Low:4.26
Close:5.20
52wk High:59.70
52wk Low:1.51
Shares:1.51M
Float Shares:725.94K
Volume Ratio:0.02
T/O Rate:31.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.5450
EPS(LYR):-0.1759
ROE:-144.99%
ROA:-69.29%
PB:0.82
PE(LYR):-25.19

Loading ...

Apimeds Subsidiary Expands Into On-Chain Insurance Services

TIPRANKS
·
Yesterday

Apimeds Unit MindWave Innovations Signs 2-Year Deal with BlockAssure to Build, Operate AssureChain Insurance Network

Reuters
·
Yesterday

Mindwave Innovations Signs 3 Client Network Agreements in 10 Days, Extending Mindchain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure

THOMSON REUTERS
·
Oct 10

Amex Halt Add Info Lst 4.940000

THOMSON REUTERS
·
Oct 05

Mindwave Innovations Signs Agreement with US-Based Blockassure to Build and Operate Assurechain, an End-to-End Insurance and Reinsurance Network

THOMSON REUTERS
·
Oct 05

Apimeds Pharmaceuticals Appoints Eric Sherb as New CFO

TIPRANKS
·
Oct 01

Apimeds Pharmaceuticals US - Appoints Eric Sherb as Chief Financial Officer Effective October 1, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 01

MindWave expands blockchain services into sports media markets

TIPRANKS
·
Sep 30

Apimeds Unit MindWave Innovations to Deploy MindChain Blockchain for AQUAEChain Platform

Reuters
·
Sep 30

Mindwave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate Flashchain for New York-Based Flash Sports & Media

THOMSON REUTERS
·
Sep 29

Mindwave Innovations: Parties Have not Publicly Disclosed Aggregate Dollar Value of Consideration Under Agreement.

THOMSON REUTERS
·
Sep 29

Amex Halt Add Info Lst 7.920000

THOMSON REUTERS
·
Sep 25

Top Midday Gainers

MT Newswires Live
·
Sep 25

Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?

TIPRANKS
·
Sep 25

Mindwave Innovations Signs Agreement to Build and Operate Aquaechain, a Platform for Insured Alci Credits

THOMSON REUTERS
·
Sep 24

Apimeds Pharmaceuticals US - Enters First Amendment to Settlement Agreement on Sept 10, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 11

Apimeds Pharmaceuticals US - Board to Consist Solely of Four Members During Interim Period - SEC Filing

THOMSON REUTERS
·
Sep 11

Apimeds Pharmaceuticals US - Board to Expand to Seven Members After Interim Period - SEC Filing

THOMSON REUTERS
·
Sep 11

Apimeds Pharmaceuticals Adds Co-CEO Sungjoon Chae to Board

Reuters
·
Sep 11

Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19

Reuters
·
Aug 22